Journal of Investigative Dermatology

Medical research

Why long-suffering hosts grow a thick skin

Occasionally, following a transplant procedure, the donor's immune cells recognize the recipient's tissues as foreign and trigger a multisystem disorder called graft-versus-host disease (GVHD). Occurring commonly after bone ...

Health

Vitamin D may improve sunburn, according to new clinical trial

High doses of vitamin D taken one hour after sunburn significantly reduce skin redness, swelling, and inflammation, according to double-blinded, placebo-controlled clinical trial out of Case Western Reserve University School ...

Oncology & Cancer

Retinol supplementation may lower melanoma risk

(HealthDay) -- Retinol supplementation is associated with a lower risk of melanoma, according to research published online March 1 in the Journal of Investigative Dermatology.

Medical research

Novel technology may prevent burn scars

A group of researchers from Tel Aviv University and Harvard University has devised a new non-invasive method to prevent burn scarring caused by the proliferation of collagen cells. They are using short, pulsed electric fields ...

Medical research

Mitochondria-targeted iron chelator offers photoprotection

(HealthDay)—A mitochondria-targeted iron chelator can protect primary skin fibroblasts against the harmful effects of ultraviolet A (UVA), according to a study published in the August issue of the Journal of Investigative ...

Immunology

Another medical cold case cracked by the MUHC's 'Dr. House'

A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and ...

Diseases, Conditions, Syndromes

Genes reveal which patients will benefit from scleroderma drug

Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth's ...

Diseases, Conditions, Syndromes

A risk factor for drug-induced skin disease identified

DPP-4 inhibitor (DPP-4i) is widely used to treat type 2 diabetes, but increased cases of bullous pemphigoid (BP) have been reported among patients taking the medicine. BP is the most common autoimmune blistering disorder, ...

page 10 from 14